CNN’s Kaitlan Collins caught up with DJ Daniel, the 13-year-old cancer survivor honored by President Donald Trump during his address to Congress.

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at $35 per month. Insulin prices rose by around 184% in a decade from 2012 to ...

Novo Nordisk has filed for approval to extend the ... a childhood obesity specialist at the University of Minnesota Medical School in Minneapolis, pointed out that, left untreated, childhood ...

an associate professor of pediatrics at the University of Minnesota. Fox serves as a principal investigator for clinical trials sponsored by both Novo Nordisk and Eli Lilly. Once the kids began ...

January 27, 2025 Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly ... Mississippi, and Minnesota. "We're fighting back against drug companies and PBMs that unacceptably and artificially inflate the ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

January 27, 2025 Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general ...

Novo Nordisk 's ( NVO 3.84%) latest move in the retail sphere was met with approval from market participants Wednesday. They bid the stock up by nearly 4% following the company's news, a performance ...

Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical companies next week. CEO Lars Jørgensen told reporters Thursday ...

Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet demand.

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...